News Channels

05 Oct 2017 Ligand to Acquire Crystal Bioscience, the Leader in Chicken-derived Fully-human Antibody Generation, for $25 Million in Cash plus Additional Potential Payments
05 Oct 2017 Chugai's Bispecific Antibody "ERY974" Results of Preclinical Study Published in Science Translational Medicine
05 Oct 2017 Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
04 Oct 2017 Palleon Pharmaceuticals Raises $47.6 Million to Develop Glycoimmune Checkpoint Inhibitors, a New Class of Medicines Designed to Overcome Resistance to First-Generation Immuno-Oncology Drugs
04 Oct 2017 Siamab Therapeutics and Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration to Develop Antibody Therapeutics Targeting Multiple Solid Tumors
04 Oct 2017 Melior Pharmaceuticals Initiates Phase 2b Study with MLR-1023 for Type 2 Diabetes
04 Oct 2017 Catabasis Pharmaceuticals Reports Positive Results from Open-Label Extension of Phase 2 MoveDMD® Trial Evaluating Edasalonexent in Duchenne Muscular Dystrophy and Plans to Initiate Phase 3 Clinical Trial in First Half 2018
04 Oct 2017 AOBiome Commences Patient Enrollment in Phase 1b/2a Clinical Trial of Ammonia Oxidizing Bacteria (AOB) for the Treatment of Seasonal Allergic Rhinitis
04 Oct 2017 Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Meniere's Disease
04 Oct 2017 ImmunoMet Announces Initiation of Phase 1 Clinical Study of IM156, an OXPHOS Inhibitor, in Patients with Solid Tumors
04 Oct 2017 RG7916 Increased SMN Protein Production in SUNFISH Clinical Trial in Patients with Type 2/3 Spinal Muscular Atrophy
04 Oct 2017 Spero Therapeutics Announces Positive Phase 1 Clinical Data From Potentiator Platform
04 Oct 2017 Motif Bio Announces Positive Topline Results for iclaprim in the REVIVE-2 Phase 3 Study
04 Oct 2017 Nimbus Therapeutics and Celgene Enter Long-Term Strategic Immunology Alliance to Develop Programs for Patients with Autoimmune Disorders
04 Oct 2017 Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration
04 Oct 2017 Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
03 Oct 2017 FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines Associated with Frontalis Muscle Activity In Adults
03 Oct 2017 Fostamatinib Meets Pre-Specified Primary Endpoint in Stage 1 of Autoimmune Hemolytic Anemia (AIHA) Phase 2 Study
03 Oct 2017 Vantia Therapeutics Announces Positive Results From its Phase III EQUINOC Study, a Pivotal Trial with Fedovapagon for the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia
03 Oct 2017 Spring Bank Pharmaceuticals Announces Presentation of Positive Preclinical Data on SB 11285 at the 2017 AACR Conference on Tumor Immunology and Immunotherapy

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing